Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.
Medicine (Baltimore). 2024 Nov 1;103(44):e40342. doi: 10.1097/MD.0000000000040342.
To study the changes of lymphocyte subsets in children with acute lymphoblastic leukemia (ALL) at initial diagnosis and compare them with those of healthy children and patients who have achieved complete remission (CR). Furthermore, we aim to analyze the prognostic significance of lymphocyte subsets in these patients. From May 2011 to December 2015, 405 children with ALL were enrolled in this study. Peripheral blood was collected at the time of diagnosis, and lymphocyte subsets were detected by flow cytometry. Then, the percentages of lymphocyte subsets in each group were compared. In addition, survival and prognostic factor analyses were performed to determine the prognostic value of lymphocyte subsets. Lymphocyte subsets in children with ALL were dramatically different from those in healthy children and patients achieving CR. Additionally, lymphocyte subsets were correlated with different minimal residual disease and risk parameters. Furthermore, percentages of CD3+ T cells and CD4+ T cells and the ratio of CD4/CD8 were associated with different clinical outcomes. Multivariate analysis demonstrated the percentage of CD4+ T cell as an independent predictor for clinical prognosis. Lymphocyte subsets in pediatric ALL undergo dramatic changes and were related to prognosis, especially CD4+ T cells.
研究初诊急性淋巴细胞白血病(ALL)患儿淋巴细胞亚群的变化,并与健康儿童和完全缓解(CR)患者进行比较。进一步分析淋巴细胞亚群在这些患者中的预后意义。
收集 2011 年 5 月至 2015 年 12 月就诊的 405 例 ALL 患儿外周血,采用流式细胞术检测淋巴细胞亚群,比较各组间淋巴细胞亚群的百分比。并进行生存及预后因素分析,以确定淋巴细胞亚群的预后价值。
ALL 患儿的淋巴细胞亚群与健康儿童和 CR 患者存在显著差异。此外,淋巴细胞亚群与不同的微小残留病和危险参数相关。而且,CD3+ T 细胞、CD4+ T 细胞的百分比和 CD4/CD8 的比值与不同的临床结局相关。多因素分析表明 CD4+ T 细胞的百分比是临床预后的独立预测因子。
儿童 ALL 中的淋巴细胞亚群发生显著变化,并与预后相关,尤其是 CD4+ T 细胞。